Search research articles
Contact Us
Filters
Showing results (91-100 of 183) with videos related to
Page
of 19
Sort By:
Journal of Mass Spectrometry : JMS
|
August 25, 2006
Sensitive inductively coupled plasma mass spectrometry assay for the determination of platinum originating from cisplatin, carboplatin, and oxaliplatin in human plasma ultrafiltrate
E E M Brouwers, M M Tibben, H Rosing, et al.
Clinical Pharmacology in Drug Development
|
January 24, 2020
Pilot Study to Predict Pharmacokinetics of a Therapeutic Gemcitabine Dose From a Microdose
M Van Nuland, H Rosing, B Thijssen, et al.
Cancer Chemotherapy and Pharmacology
|
August 19, 2004
Oral bioavailability of docetaxel in combination with OC144-093 (ONT-093)
I E L M Kuppens, T M Bosch, M J van Maanen, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
April 12, 2016
Corrigendum to "Development and validation of LC-MS/MS assays for the quantification of bendamustine and its metabolites in human plasma and urine" [J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 893-894 (2012) 92-100]
A C Dubbelman, M Tibben, H Rosing, et al.
Nuclear Medicine Communications
|
September 1, 1995
Renal excretion of meta-iodobenzylguanidine after therapeutic doses in cancer patients and its relation to dose and creatinine clearance
A R Wafelman, Y L Nortier, H Rosing, et al.
Journal of Mass Spectrometry : JMS
|
February 11, 2003
Rapid quantification of HIV protease inhibitors in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry
K M L Crommentuyn, H Rosing, L G A H Nan-Offeringa, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
March 20, 2012
Development and validation of LC-MS/MS assays for the quantification of bendamustine and its metabolites in human plasma and urine
A C Dubbelman, M Tibben, H Rosing, et al.
Investigational New Drugs
|
December 16, 1998
Pharmaceutical development of a parenteral lyophilized formulation of the investigational antitumor neuropeptide antagonist [Arg6, D-Trp7,9, MePhe8]-Substance P [6-11]
J D Jonkman-de Vries, H Rosing, H Talsma, et al.
Cancer Chemotherapy and Pharmacology
|
October 30, 2013
Safety and pharmacology of gemcitabine and capecitabine in patients with advanced pancreatico-biliary cancer and hepatic dysfunction
M Joerger, A D R Huitema, D Koeberle, et al.
Bioanalysis
|
November 24, 2012
Quantitative determination of erlotinib and O-desmethyl erlotinib in human EDTA plasma and lung tumor tissue
N A G Lankheet, E E Schaake, H Rosing, et al.
Page
of 19
Search research articles
Search
Showing results (91-100 of 183) with videos related to
Sort By:
Page
of 19
Journal of Mass Spectrometry : JMS
|
August 25, 2006
Sensitive inductively coupled plasma mass spectrometry assay for the determination of platinum originating from cisplatin, carboplatin, and oxaliplatin in human plasma ultrafiltrate
E E M Brouwers, M M Tibben, H Rosing, et al.
Clinical Pharmacology in Drug Development
|
January 24, 2020
Pilot Study to Predict Pharmacokinetics of a Therapeutic Gemcitabine Dose From a Microdose
M Van Nuland, H Rosing, B Thijssen, et al.
Cancer Chemotherapy and Pharmacology
|
August 19, 2004
Oral bioavailability of docetaxel in combination with OC144-093 (ONT-093)
I E L M Kuppens, T M Bosch, M J van Maanen, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
April 12, 2016
Corrigendum to "Development and validation of LC-MS/MS assays for the quantification of bendamustine and its metabolites in human plasma and urine" [J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 893-894 (2012) 92-100]
A C Dubbelman, M Tibben, H Rosing, et al.
Nuclear Medicine Communications
|
September 1, 1995
Renal excretion of meta-iodobenzylguanidine after therapeutic doses in cancer patients and its relation to dose and creatinine clearance
A R Wafelman, Y L Nortier, H Rosing, et al.
Journal of Mass Spectrometry : JMS
|
February 11, 2003
Rapid quantification of HIV protease inhibitors in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry
K M L Crommentuyn, H Rosing, L G A H Nan-Offeringa, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
March 20, 2012
Development and validation of LC-MS/MS assays for the quantification of bendamustine and its metabolites in human plasma and urine
A C Dubbelman, M Tibben, H Rosing, et al.
Investigational New Drugs
|
December 16, 1998
Pharmaceutical development of a parenteral lyophilized formulation of the investigational antitumor neuropeptide antagonist [Arg6, D-Trp7,9, MePhe8]-Substance P [6-11]
J D Jonkman-de Vries, H Rosing, H Talsma, et al.
Cancer Chemotherapy and Pharmacology
|
October 30, 2013
Safety and pharmacology of gemcitabine and capecitabine in patients with advanced pancreatico-biliary cancer and hepatic dysfunction
M Joerger, A D R Huitema, D Koeberle, et al.
Bioanalysis
|
November 24, 2012
Quantitative determination of erlotinib and O-desmethyl erlotinib in human EDTA plasma and lung tumor tissue
N A G Lankheet, E E Schaake, H Rosing, et al.
Page
of 19